(Q63248442)

15

object named as

Helen M Lazear

0 references

Aravinda M. de Silva

17

object named as

Aravinda M de Silva

0 references

author name string

Huy A Tu

2

0 references

Ciara Gimblet-Ochieng

3

0 references

Guei-Jiun Alice Liou

4

0 references

Ramesh S Jadi

5

0 references

Stefan W Metz

6

0 references

Ashlie Thomas

7

0 references

Benjamin D McElvany

8

0 references

Edgar Davidson

9

0 references

Benjamin J Doranz

10

0 references

Yaoska Reyes

11

0 references

Natalie M Bowman

12

0 references

Sylvia Becker-Dreps

13

0 references

Filemón Bucardo

14

0 references

Sean A Diehl

Three-dimensional structure of an antigen-antibody complex at 2.8 A resolution

16

0 references

language of work or name

English

0 references

publication date

18 April 2019

0 references

published in

JCI insight

0 references

volume

4

0 references

issue

8

0 references

cites work

1 reference

12 December 2020

Protection against Japanese encephalitis by inactivated vaccines

1 reference

12 December 2020

Replacing the complementarity-determining regions in a human antibody with those from a mouse

1 reference

12 December 2020

Dengue Virus-Specific and Flavivirus Group Determinants Identified with Monoclonal Antibodies by Indirect Immunofluorescence

1 reference

12 December 2020

Persistence of neutralizing antibody 30-35 years after immunization with 17D yellow fever vaccine

1 reference

12 December 2020

Codon bias targets mutation.

1 reference

12 December 2020

Clonal selection and learning in the antibody system

1 reference

12 December 2020

Anatomy of hot spots in protein interfaces

1 reference

12 December 2020

The atomic structure of protein-protein recognition sites

1 reference

12 December 2020

A ligand-binding pocket in the dengue virus envelope glycoprotein

1 reference

12 December 2020

Zika virus. I. Isolations and serological specificity

1 reference

12 December 2020

Equine vaccine for West Nile virus

1 reference

12 December 2020

Protection against tick-borne encephalitis with a new vaccine formulation free of protein-derived stabilizers

1 reference

12 December 2020

STAT3-mediated up-regulation of BLIMP1 Is coordinated with BCL6 down-regulation to control human plasma cell differentiation.

1 reference

12 December 2020

Genetic and serologic properties of Zika virus associated with an epidemic, Yap State, Micronesia, 2007

1 reference

12 December 2020

Rapid generation of fully human monoclonal antibodies specific to a vaccinating antigen

1 reference

12 December 2020

Impact of Quaternary Organization on the Antigenic Structure of the Tick-Borne Encephalitis Virus Envelope Glycoprotein E

1 reference

12 December 2020

Generation of stable monoclonal antibody-producing B cell receptor-positive human memory B cells by genetic programming

1 reference

12 December 2020

The human immune response to Dengue virus is dominated by highly cross-reactive antibodies endowed with neutralizing and enhancing activity

1 reference

12 December 2020

Neutralization of West Nile virus by cross-linking of its surface proteins with Fab fragments of the human monoclonal antibody CR4354

1 reference

12 December 2020

B-cell responses during primary and secondary dengue virus infections in humans

1 reference

12 December 2020

Persistence of circulating memory B cell clones with potential for dengue virus disease enhancement for decades following infection

1 reference

12 December 2020

The human antibody response to dengue virus infection

1 reference

12 December 2020

Genetic characterization of Zika virus strains: geographic expansion of the Asian lineage

1 reference

12 December 2020

Identification of human neutralizing antibodies that bind to complex epitopes on dengue virions

1 reference

12 December 2020

Antibodies targeting dengue virus envelope domain III are not required for serotype-specific protection or prevention of enhancement in vivo

1 reference

12 December 2020

The structural basis for serotype-specific neutralization of dengue virus by a human antibody

1 reference

12 December 2020

Somatic Mutations of the Immunoglobulin Framework Are Generally Required for Broad and Potent HIV-1 Neutralization

1 reference

12 December 2020

The global distribution and burden of dengue

1 reference

12 December 2020

Efficacy and duration of immunity after yellow fever vaccination: systematic review on the need for a booster every 10 years.

1 reference

12 December 2020

T-cell immunity to infection with dengue virus in humans

1 reference

12 December 2020

A high-throughput shotgun mutagenesis approach to mapping B-cell antibody epitopes

1 reference

12 December 2020

Complete Coding Sequence of Zika Virus from a French Polynesia Outbreak in 2013

1 reference

12 December 2020

A new class of highly potent, broadly neutralizing antibodies isolated from viremic patients infected with dengue virus

1 reference

12 December 2020

A highly potent human antibody neutralizes dengue virus serotype 3 by binding across three surface proteins

1 reference

12 December 2020

Robust and Balanced Immune Responses to All 4 Dengue Virus Serotypes Following Administration of a Single Dose of a Live Attenuated Tetravalent Dengue Vaccine to Healthy, Flavivirus-Naive Adults

1 reference

12 December 2020

Single-Cell Analysis of B Cell/Antibody Cross-Reactivity Using a Novel Multicolor FluoroSpot Assay

1 reference

12 December 2020

Analysis of Dengue Virus Genetic Diversity during Human and Mosquito Infection Reveals Genetic Constraints

1 reference

12 December 2020

A new quaternary structure epitope on dengue virus serotype 2 is the target of durable type-specific neutralizing antibodies

1 reference

12 December 2020

Vaccination Against Dengue: Challenges and Current Developments

1 reference

12 December 2020

Zika Virus in the Americas — Yet Another Arbovirus Threat

1 reference

12 December 2020

Zika Virus: New Clinical Syndromes and Its Emergence in the Western Hemisphere

1 reference

12 December 2020

1 reference

12 December 2020

The 3.8 Å resolution cryo-EM structure of Zika virus

1 reference

12 December 2020

A Mouse Model of Zika Virus Pathogenesis

1 reference

12 December 2020

Phylogeny of Zika Virus in Western Hemisphere, 2015

1 reference

12 December 2020

Structure of the thermally stable Zika virus

1 reference

12 December 2020

Interim Guidance for Interpretation of Zika Virus Antibody Test Results

1 reference

12 December 2020

Dengue virus sero-cross-reactivity drives antibody-dependent enhancement of infection with zika virus

1 reference

12 December 2020

Human antibody responses after dengue virus infection are highly cross-reactive to Zika virus

1 reference

12 December 2020

Specificity, cross-reactivity and function of antibodies elicited by Zika virus infection

1 reference

12 December 2020

Dengue Virus Envelope Dimer Epitope Monoclonal Antibodies Isolated from Dengue Patients Are Protective against Zika Virus

1 reference

12 December 2020

Broadly Neutralizing Activity of Zika Virus-Immune Sera Identifies a Single Viral Serotype

1 reference

12 December 2020

Zika-induced antibody response enhances dengue serotype 2 replication in vitro

1 reference

12 December 2020

Diagnostics for Zika virus on the horizon

1 reference

12 December 2020

Refined protocol for generating monoclonal antibodies from single human and murine B cells

1 reference

12 December 2020

Neutralizing human antibodies prevent Zika virus replication and fetal disease in mice

1 reference

12 December 2020

Heterologous Protection against Asian Zika Virus Challenge in Rhesus Macaques

1 reference

12 December 2020

Molecular determinants of human neutralizing antibodies isolated from a patient infected with Zika virus

1 reference

12 December 2020

Mapping the Human Memory B Cell and Serum Neutralizing Antibody Responses to DENV4 Infection and Vaccination

1 reference

12 December 2020

Dengue Virus-Specific Antibodies Enhance Brazilian Zika Virus Infection

1 reference

12 December 2020

Dengue virus antibodies enhance Zika virus infection

1 reference

12 December 2020

Yellow Fever — Once Again on the Radar Screen in the Americas

1 reference

12 December 2020

Biologic Evidence Required for Zika Disease Enhancement by Dengue Antibodies

1 reference

12 December 2020

Enhancement of Zika virus pathogenesis by preexisting antiflavivirus immunity

1 reference

12 December 2020

Lack of Durable Cross-Neutralizing Antibodies Against Zika Virus from Dengue Virus Infection

1 reference

12 December 2020

Recurrent Potent Human Neutralizing Antibodies to Zika Virus in Brazil and Mexico

1 reference

12 December 2020

Maternal Zika Virus Disease Severity, Virus Load, Prior Dengue Antibodies and their Relationship to Birth Outcomes.

1 reference

12 December 2020

Host response: Cross-fit T cells battle Zika virus

1 reference

12 December 2020

Delineating antibody recognition against Zika virus during natural infection

1 reference

12 December 2020

Zika virus pathogenesis in rhesus macaques is unaffected by pre-existing immunity to dengue virus

1 reference

12 December 2020

In Vitro Assembly and Stabilization of Dengue and Zika Virus Envelope Protein Homo-Dimers

1 reference

12 December 2020

Antibody-based assay discriminates Zika virus infection from other flaviviruses

1 reference

12 December 2020

Progress and Works in Progress: Update on Flavivirus Vaccine Development

1 reference

12 December 2020

Impact of prior flavivirus immunity on Zika virus infection in rhesus macaques

1 reference

12 December 2020

Zika virus activates de novo and cross-reactive memory B cell responses in dengue-experienced donors.

1 reference

12 December 2020

Prior Exposure to Zika Virus Significantly Enhances Peak Dengue-2 Viremia in Rhesus Macaques

1 reference

12 December 2020

A Human Bi-specific Antibody against Zika Virus with High Therapeutic Potential

1 reference

12 December 2020

Innate, T and B Cell Responses in Acute Human Zika Patients

1 reference

12 December 2020

Antibody-dependent enhancement of severe dengue disease in humans.

1 reference

12 December 2020

Development of envelope protein antigens to serologically differentiate Zika from dengue virus infection.

1 reference

12 December 2020

The Zika virus envelope protein glycan loop regulates virion antigenicity.

1 reference

12 December 2020

Dengue virus-like particles mimic the antigenic properties of the infectious dengue virus envelope.

1 reference

12 December 2020

Longitudinal Analysis of Antibody Cross-Neutralization Following Zika and Dengue Virus Infection in Asia and the Americas.

1 reference

12 December 2020